• 86 (0.80-0.93)], and no effect in at-risk patients without history of cardiovascular events . We observed a trend toward larger treatment benefits with SGLT-2i among patients with chronic kidney disease , and patients with uncontrolled diabetes for both GLP1-RA or SGLT-2i . Uncontrolled hypertension, obesity, gender, age and race did not appear to…[Read more]

  • 1%)] and the non-sarcopenia group , P = 0.1778). The rate of perforation and the rate of delayed bleeding were not significantly different between the sarcopenia group and the non-sarcopenia group .

    The presence of sarcopenia did not influence the rate of complications after ESD. Colorectal ESD is safe and effective even in patients wit…[Read more]

  • Axelsen McGee became a registered member 6 months, 4 weeks ago